ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $97,000 | -97.3% | 19,324 | -85.8% | 0.00% | -100.0% |
Q4 2020 | $3,548,000 | -23.7% | 136,477 | +9.1% | 0.01% | -28.6% |
Q3 2020 | $4,649,000 | -27.5% | 125,062 | +0.1% | 0.01% | -41.7% |
Q2 2020 | $6,410,000 | +432.8% | 124,931 | +227.6% | 0.01% | +300.0% |
Q1 2020 | $1,203,000 | – | 38,139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
EMC Capital Management | 27,566 | $583,000 | 0.33% |
WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |